About Us

At ImmuneID, we transform precision immunology by combining our proprietary ImmuneID platform together with advanced bioinformatic analysis and deep knowledge of immune system biology. We are passionate, love tough problems and never shy away from new challenges. We believe in a culture of integrity, transparency, communication, and accountability. We trust our staff to perform to the best of their abilities. Above all, we are a team motivated by patient success.

Our Team

Christoph Westphal, MD PhD
Executive Chair, ImmuneID Partner, Longwood Fund
David H. Donabedian, PhD

CEO, ImmuneID

Annalisa D’Andrea PhD

President and CSO, ImmuneID

Jeff Capello, MBA
CFO/COO, ImmuneID
Thomas Haag, JD PhD
Head of IP, ImmuneID

Our Founders and Advisors

Steve Elledge, PhD
Tomasz Kula, PhD
H. Benjamin Larman, PhD
Michael Mina, MD PhD
David Walt PhD

Our Board of Directors

David H. Donabedian, PhD

CEO, ImmuneID

Ittai Harel, MBA
ImmuneID, BOD
Managing Partner, Pitango

Peter Hutt, JD

GC, ImmuneID BOD
Senior Counsel, Covington & Burling LLP
Dan Janney

ImmuneID BOD
Managing Partner, Alta Partners

Steve Kafka, PhD

ImmuneID BOD
Managing Partner, Section 32

Christoph Westphal,
MD PhD

Executive Chair, ImmuneID
Partner, Longwood Fund

Investors